Myopia; Refractive Error
9
4
4
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
Evaluation of Novel Spectacles Intended for Myopia Management in a Short-Term Study
Peripheral Relative Refractive Power of Orthokeratology Lenses
Optimizing Light Exposure for Myopia Prevention and Control (LightSPAN)
Measuring Changes In Choroidal Thickness Induced By Prototype Soft Contact Lenses Worn For 1 Hour
AOSLO-Based Precise Measurement of Retinal Hemodynamics: Development and Application Assessment
Clinical Study of SMILE 4.0-VISULYZE in Correcting Refractive Errors
The Objective of This Study is to Evaluate the Perfomance of a Photorefraction Device for Screening Ametropia in Children. Eligible Participants Will Undergo Multiple Refractive Error Measurements, Visual Acuity and Strabismus Assessments During a Single Evaluation Visit.
Efficacy and Visual Quality of Orthokeratology Lenses With Different Designs
The Initiating Factors of Myopia Among Primary and Secondary School Students in Tianjin